Best Practices For Creating Quality Agreements

Download as pdf or txt
Download as pdf or txt
You are on page 1of 33

QUALITY AGREEMENTS

John J. Vajda
BFC Consultants
©2009
SCENARIO
Contract signed for manufacturing
Everyone happy
What do we do next?
HISTORY
First appeared in UK MCA in 1991 called a
Technical Agreement
Currently it is the “MCA Rules and
Guidance for Pharmaceutical Manufacturers
and Distributors, 2002”
Also known as the Orange Book
HISTORY…
FDA “Guidance for Industry: Cooperative
Manufacturing Arrangements for Licensed
Biologics” August 1999 best US reference
Gives some examples of differences
between Quality Agreements and business
agreements
PURPOSE
To define in detail the functional aspects of
the relationship
Establish responsibilities for Quality and
Production personnel for each party
YOU MUST
Assure the Contractor is qualified
Audit GMP compliance
Provide ALL information required
Explain hazards
CONTRACTOR MUST
Have adequate resources
Approved raw material sources
Assure quality
Not ”farm out”
FDA GUIDANCE SUGGESTS
Identification and location of contractor
Defined responsibilities of each party
Description of materials provided for the
Contractor and details of shipment
Operations to be performed by the
Contractor
Mutually agreed documentation package
FDA GUIDANCE
SUGGESTS…
Contractor must agree to:
 Provide notification of any changes
 To facility
 To manufacturing process
 To material sources
 To other products being made
 Provide notification of deviations
Agreement on audits
HOW TO STRUCTURE A QUALITY AGREEMENT

Legal document, needs legal review


STAND-ALONE OR?
Con Pro
 Legal objections  Can be updated
 If product is biologic and sold  Readily available
in Europe  Available for inspections
WHAT’S THE CONTRACT?
Written document
Technically sound
Defined responsibilities
Access to
 Records
 Premises
 Samples
WHAT’S THE CONTRACT?…
Allow visits
Define release criteria
 Must meet marketing needs
Sampling locations
KEY CONTENTS

This is NOT a comprehensive list.


Other points may be added depending on
specific needs and corporate cultures.
WHAT DOES NOT BELONG
Business terms and conditions
Pricing
Forecasts and delivery terms
Confidentiality agreement
Liability and dispute resolution issues
These belong in a separate Business
Agreement!
DISPUTE RESOLUTIONS
Refer to in Quality Agreement but keep
details in Business Agreement
Potential issues
 Testing
 Release
 Documentation
RESPONSIBILITIES
Need to be clearly defined without any
ambiguity!
If in doubt as to what to include follow 21
CFR 211 and assign which company is
doing which section
COMMUNICATION
Will eliminate:
 “ I thought …”
 “ Not sure”
 “ Don’t know”
 “ Did not think it was important”
Assignment of personnel by both parties
including contact information
COMMUNICATION…
Timeliness
Communicating Quality issues
 We want it NOW! (YOU)
 We want to investigate first (contractor)
DOCUMENTATION
Who is writing what?
Who is approving what?
What governs if multiple documents apply
Summaries vs. full reports
Retention and ownership
BATCH IDENTIFICATION
Parties will have different systems
How will product be identified
Explain all codes to eliminate
misunderstandings
DEVIATIONS
How to classify? minor vs., catastrophic
Responsibility for reporting, trending and
resolution
Time is of the essence!
Who can approve what?
DEVIATIONS…
Define expectations for communications
Provide examples of major deviations
AUDITS
Visit vs. audit vs. inspection
On- site rep vs. periodic
Frequency
Any costs or limitations?
What to do if FDA comes
 Will you participate. How?
SAMPLING AND TESTING
Batch records
What is acceptable?
 Purity, stability, expiration
What method?
Who is testing what?
Third party labs
 Qualifications
SAMPLING AND TESTING…
Who is approving what?
 Retention
 Shelf life
International requirements
SUBCONTRACTING
Is it allowed?
If so, how is it approved?
 Right to audit
PROBLEMS
Complaints
 How they are:
 Received
 Communicated
 Investigated
 Reported
Recalls
ANNUAL REVIEW
What to include?
Format
 Template
Timing
AGREEMENT APPROVAL
QA for both parties
Operations
Legal
Others
 Marketing
 BD
REFERENCES
“UK MCA Rules and Guidance for
Pharmaceutical Manufacturers and
Distributors 2002”
FDA “Guidance for Industry, Cooperative
Manufacturing Agreements for Licensed
Biologics”
FDA 21CFR211
CONTACT INFORMATION
BFC Consultants
John J. Vajda
Phone: 408-640-9158
E-mail: [email protected]
Web: www.bfcconsultants.com
QUESTIONS

You might also like